Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use CAMPRAL safely and effectively. See full prescribing information for CAMPRAL. CAMPRAL® (acamprosate calcium) Delayed-Release Tablets Initial U.S. Approval: 2004
Medication labelWhy this: Advisory · dailymed-prescription
Campral® is indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation. Treatment with Campral should be part of a comprehensive management program that includes psychosocial support. The efficacy of Campral in promoting abstinence has not been demonstrated in subjects who have not undergone detoxification and not achieved alcohol abstinence prior to beginning Campral treatment. The efficacy of Campral in promoting abstinence from alcohol in polysubstance abusers has not been adequately assessed.
- generic_name
- acamprosate calcium
- product_names
- acamprosate calcium
- ndc
- 68151-4760, 0456-3330, 68151-4760-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en